![Frank Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Lee
Vorstandsvorsitzender bei
PACIRA BIOSCIENCES, INC.
Vermögen: 16 Mio $ am 31.05.2026
Profil
Frank D.
Lee is Chief Executive Officer & Director at Pacira Biosciences, Inc. since 2024.
Mr. Lee is Chief Executive Officer & Director at Flexion Therapeutics, Inc. Mr. Lee is Executive Chairman at Therini Bio, Inc. since 2023.
Mr. Lee is Chairman at Catamaran Bio, Inc. since 2022.
Mr. Lee is Independent Director at Bausch Health Cos., Inc. since 2024.
Mr. Lee is Advisor at LSV Capital Management LLC since 2023.
Formerly, Mr. Lee was President, Chief Executive Officer & Director at Forma Therapeutics Holdings, Inc. from 2019 to 2022.
Mr. Lee was President, Chief Executive Officer & Director at Forma Therapeutics, Inc. from 2019 to 2022.
Mr. Lee was Director at The Genentech Foundation.
Mr. Lee was Independent Director at Bolt Biotherapeutics, Inc. from 2021 to 2024.
Mr. Lee was Senior Vice President-Global Product Strategy at Genentech, Inc. from 2006 to 2019.
Mr. Lee was Member at Roche Group.
Education includes an undergraduate degree from Vanderbilt University in 1996 and an MBA from The Wharton School of the University of Pennsylvania in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 660’830 ( 1.68% ) | 15 Mio $ | 31.05.2026 | |
| 22.05.2026 | 95’210 ( 0.03% ) | 510 326 $ | 31.05.2026 |
Aktive Positionen von Frank Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Vorstandsvorsitzender | 02.01.2024 |
| BAUSCH HEALTH COMPANIES INC. | Direktor/Vorstandsmitglied | 14.05.2024 |
| FLEXION THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Vorsitzender | 05.04.2022 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Vorsitzender | 15.05.2023 |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Berater | 01.02.2023 |
Ehemalige bekannte Positionen von Frank Lee
| Unternehmen | Position | Ende |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.09.2024 |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Vorstandsvorsitzender | 01.10.2022 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Vorstandsvorsitzender | 01.10.2022 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Frank Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
